Evidence map›Paper›PMID 30392133›Full record

ReviewPsychopharmacology2019

Role of prefrontal cortex in the extinction of drug memories.

Wen-Hua Zhang, Ke-Xin Cao, Zeng-Bo Ding, Jian-Li Yang, Bing-Xing Pan, Yan-Xue Xue

Abstract readReview
PubMed Publisher
In one paragraph

Review in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. The Top-Down of Prefrontal Cortex to the Hippocampus Glutamatergic Pathway Regulates Reward Memory of Methamphetamine.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Modulation of neuronal excitability by binge alcohol drinking.Frontiers in molecular neuroscience · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wen-Hua ZhangLaboratory of Fear and Anxiety Disorders, Institute of Life Science, Nanchang University, Nanchang, 330031, China.
Ke-Xin CaoTianjin General Hospital, Tianjin Medical University, Tianjin, 300052, China.
Zeng-Bo DingNational Institute on Drug Dependence, and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, 100191, China.
Jian-Li YangTianjin General Hospital, Tianjin Medical University, Tianjin, 300052, China.
Bing-Xing PanLaboratory of Fear and Anxiety Disorders, Institute of Life Science, Nanchang University, Nanchang, 330031, China. panbingxing@ncu.edu.cn.
Yan-Xue XueNational Institute on Drug Dependence, and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, 100191, China. yanxuexue@bjmu.edu.cn.

Funding

National Basic Research Program of China 2014CB846100National Basic Research Program of China 2015CB559200National Natural Science Foundation of China 31700916National Natural Science Foundation of China 81601179National Natural Science Foundation of China 81771459
6 · The paper itself

Abstract

It has been recognized that drug addiction engages aberrant process of learning and memory, and substantial studies have focused on developing effective treatment to erase the enduring drug memories to reduce the propensity to relapse. Extinction, a behavioral intervention exposing the individuals to the drug-associated cues repeatedly, can weaken the craving and relapse induced by drug-associated cues, but its clinic efficacy is limited. A clear understanding of the neuronal circuitry and molecular mechanism underlying extinction of drug memory will facilitate the successful use of extinction therapy in clinic. As a key component of mesolimbic system, medial prefrontal cortex (mPFC) has received particular attention largely in that PFC stands at the core of neural circuits for memory extinction and manipulating mPFC influences extinction of drug memories and subsequent relapse. Here, we review the recent advances in both animal models of drug abuse and human addicted patients toward the understanding of the mechanistic link between mPFC and drug memory, with particular emphasis on how mPFC contributes to the extinction of drug memory at levels ranging from neuronal architecture, synaptic plasticity to molecular signaling and epigenetic regulation, and discuss the clinic relevance of manipulating the extinction process of drug memory to prevent craving and relapse through enhancing mPFC function.

Indexed as

AnimalsAssociation LearningCuesDisease Models, AnimalExtinction, PsychologicalHumansMaleMemoryNerve NetNeuronal PlasticityNeuronsPrefrontal CortexRecurrenceSubstance-Related DisordersDrug memoryExtinctionPrefrontal cortexRelapse

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.